Nonparametric non-inferiority analyses in the three-arm design with active control and placebo

Statistics in Medicine

Volumn 28, Issue 29, 2009, Pages 3643-3656

  Munze, Ullrich ^a  

^a VIATRIS GmbH and Co KG   (Germany)

Author keywords

Fieller confidence interval; Multicentre study; Rank test; Relative effect

Indexed keywords

PLACEBO; THIOCTIC ACID;

ACCURACY; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; DIABETIC NEUROPATHY; HUMAN; MATHEMATICAL ANALYSIS; METHODOLOGY; NONPARAMETRIC TEST; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SIMULATION; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; COMPUTER SIMULATION; DIABETIC NEUROPATHIES; HUMANS; MULTICENTER STUDIES AS TOPIC; PAIN; STATISTICS, NONPARAMETRIC; THERAPEUTIC EQUIVALENCY; THIOCTIC ACID;

EID: 72849146423     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3727     Document Type: Article

References (23)

1. ICH Topic E10. Choice of control group in clinical trials, 2000. Available from: http://www.emea.europa.eu/pdfs/human/ich/036496en.pdf.
2. Points to consider on the clinical requirements on modified release products submitted as a line extension of existing marketing authorisations, 2003. Available from: http://www.emea.europa.eu/pdfs/human/ewp/187503en.pdf.
3. Note for guidance on clinical requirements for locally applied, locally acting products, containing known constitutions, 1995. Available from: http://www.emea.europa.eu/pdfs/human/ewp/023995en.pdf.
4. Guideline on the choice of the non-inferiority margin, 2005. Available from: http://www.emea.europa.eu/pdfs/human/ewp/215899en.pdf.
5. Hauschke D, Pigeot I. Establishing efficacy of a new experimental treatment in the 'gold standard' design. Biometrical Journal 2005; 47:782-786. DOI: 10.1002/bimj.200510169.
6. Pigeot I, Schäfer J, Röhmel J, Hauschke D. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo. Statistics in Medicine 2003; 22:883-899. DOI: 10:1002/sim.1450. (Pubitemid 36322092)
7. Koch A, Röhmel J. Hypothesis testing in the 'gold standard' design for proving the efficacy of an experimental treatment relative to placebo and a reference. Journal of Biopharmaceutical Statistics 2004; 14:315-325. DOI:10.1081/BIP-120037182.
8. Mielke M, Munk A, Schacht A. The assessment of non-inferiority in a gold standard design with censored, exponentially distributed endpoints. Statistics in Medicine 2008; 27:5093-5110. DOI: 10.1002/sim.3348.
9. Hasler M, Vonk R, Hothorn LA. Assessing non-inferiority of a new treatment in a three-arm trial in the presence of heteroscedasticity. Statistics in Medicine 2008; 27:490-503. DOI: 10.1002/sim.3052. (Pubitemid 351266337)
10. Brunner E, Dette H, Munk A. Box-type approximations in nonparametric factorial designs. Journal of the American Statistical Association 1997; 92:1494-1502. (Pubitemid 127387255)
11. Brunner E, Puri ML. Nonparametric methods in factorial designs. Statistical Papers 2001; 42:1-52. DOI: 10.1007/s003620000039.
12. Munzel U, Hauschke D. A nonparametric test for proving noninferiority in clinical trials with ordered categorical data. Pharmaceutical Statistics 2003; 2:31-37. DOI: 10.1002/pst.17.
13. Wellek S. A new approach to equivalence assessment in standard comparative bioavailability trials by means of the Mann-Whitney statistic. Biometrical Journal 1996; 38:695-710. DOI: 10.1002/bimj.4710380608. (Pubitemid 126342747)
14. Freitag G, Lange S, Munk A. Non-parametric assessment of non-inferiority with censored data. Statistics in Medicine 2006; 25:1201-1217. DOI: 10.1002/sim.2444.
15. Duchateau L, Janssen P. Pairwise non-parametric non-inferiority tests in 3 x 3 cross-over trials: should we adjust for period? Statistics in Medicine 2005; 24:1525-1536. DOI: 10.1002/sim.2048. (Pubitemid 40716351)
16. Fieller EC. A fundamental formula in the statistics of biological assay, and some applications. Quarterly Journal of Pharmacy and Pharmacology 1944; 17:117-123.
17. Finney DJ. The statistical structure of biological assays. Journal of the Japan Statistical Society 1977; 7:1-9.
18. Brunner E, Munzel U. The nonparametric Behrens - Fisher problem: asymptotic theory and a small sample approximation. Biometrical Journal 2000; 42:17-25. DOI: 10.1002/(SICI)1521-4036(200001)42:1〈17::AIDBIMJ17〉3.0. CO;2-U.
19. Kulle B. Nichtparametrisches Behrens - Fisher-Problem im Mehr-Stichprobenfall. Diploma Thesis at the University of Goettingen, 1999. Available at: http://www.ams.med.uni-goettingen.de/de/for/Thesis.html (German).
20. Brunner E, Munzel U. Nichtparametrische Datenanalyse. Springer: Berlin, Heidelberg, 2002 (German).
21. Röhmel J. On confidence bounds for the ratio of net differences in the gold standard design with reference, experimental, and placebo treatment. Biometrical Journal 2005; 47:799-806. DOI: 10.1002/bimj.200510178. (Pubitemid 43037331)
22. Munzel U, Brunner E. Nonparametric tests in the unbalanced multivariate one-way design. Biometrical Journal 2000; 42:837-854. DOI: 10.1002/1521- 4036(200011)42:7〈837::AID-BIMJ837〉3.0.CO;2-S.
23. Munzel U, Hothorn L. A unified approach to simultaneous rank test procedures in the unbalanced one-way layout. Biometrical Journal 2001; 43:553-569. DOI: 10.1002/1521-4036(200109)43:5〈553::AID-BIMJ553〉3.0. CO;2-N. (Pubitemid 33333129)